A detailed history of Nations Financial Group Inc, transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Nations Financial Group Inc, holds 13,734 shares of HALO stock, worth $652,914. This represents 0.06% of its overall portfolio holdings.

Number of Shares
13,734
Previous 12,919 6.31%
Holding current value
$652,914
Previous $676,000 16.12%
% of portfolio
0.06%
Previous 0.06%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$51.3 - $64.42 $41,809 - $52,502
815 Added 6.31%
13,734 $785,000
Q2 2024

Jul 29, 2024

BUY
$37.81 - $52.4 $131,578 - $182,352
3,480 Added 36.87%
12,919 $676,000
Q1 2024

Apr 23, 2024

BUY
$33.68 - $41.95 $103,296 - $128,660
3,067 Added 48.13%
9,439 $383,000
Q4 2023

Feb 09, 2024

BUY
$33.32 - $42.1 $212,315 - $268,261
6,372 New
6,372 $235,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.62B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Nations Financial Group Inc, Portfolio

Follow Nations Financial Group Inc, and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nations Financial Group Inc, , based on Form 13F filings with the SEC.

News

Stay updated on Nations Financial Group Inc, with notifications on news.